Bringing Expertise To Clinical Trials

When small and mid-sized biopharmaceutical firms that are on the cusp of advancing their therapies into clinical trials, the stakes become significantly elevated. The pivotal question looms: will these therapies prove safe and effective in a clinical environment, or will researchers be compelled to return to the drawing board for further refinement? For many of these burgeoning companies, which have invested years of effort exclusively into the development of their treatments, the prospect of entering the clinical trial phase can be rather intimidating. This is precisely where companies like Veristat step in, providing invaluable clinical development services and expertise to facilitate this crucial transition.

Veristat, a scientifically-oriented Clinical Research Organization (CRO), distinguishes itself through its well-established reputation for executing comprehensive, efficient, and meticulously planned studies. Ryad Ramda, the Associate Director of Data Management at Veristat, elucidates the company's approach: "We really help guide our clients, working with them to understand their most difficult challenges and what they are trying to accomplish. Having done this many, many times before, we can use our knowledge and our best practices to design and execute the right path for them"

In order to fortify their adherence to best practices and furnish clients with optimal solutions, Veristat identified the necessity for an Electronic Data Capture (EDC) solution capable of accommodating a diverse array of study types and parameters.

Discover how Zelta was able to help the company simplify and increase efficiency throughout its clinical trials by downloading the case study below.